Hugh M. Cole

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Ben Harshbarger, as attorney-in-fact for Hugh Cole
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hugh M. Cole:

Company Role Class Num Shares Value Price $ Report Date Ownership
Jounce Therapeutics, Inc. Chief Operating Officer Common Stock 110,082 $203,652 $1.85 10 Jan 2023 Direct
Astria Therapeutics, Inc. Director Stock Option (Right to Buy) 26,550 11 Jun 2025 Direct

Insider Reports Filed by Hugh M. Cole

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ATXS Astria Therapeutics, Inc. 11 Jun 2025 1 $0 4 Director 12 Jun 2025, 19:14
ATXS Astria Therapeutics, Inc. 05 Jun 2024 1 $0 4 Director 06 Jun 2024, 16:05
ATXS Astria Therapeutics, Inc. 02 Jun 2023 1 $0 4 Director 06 Jun 2023, 08:05
/report/000164045523000008-cole-hugh-m-2023-01-09 Jounce Therapeutics, Inc. 09 Jan 2023 2 -$18,481 4 Chief Operating Officer 11 Jan 2023, 19:29
/report/000164045522000084-cole-hugh-m-2022-08-01 Jounce Therapeutics, Inc. 01 Aug 2022 2 $0 4 Chief Operating Officer 03 Aug 2022, 20:29
ATXS Astria Therapeutics, Inc. 09 Jun 2022 1 $0 4/A Director 21 Jun 2022, 08:32
/report/000164045522000035-cole-hugh-m-2022-02-01-restatement Jounce Therapeutics, Inc. 01 Feb 2022 1 $0 4/A Chief Business Officer 17 Mar 2022, 20:50
/report/000164045522000008-cole-hugh-m-2022-01-07 Jounce Therapeutics, Inc. 07 Jan 2022 2 -$66,580 4 Chief Business Officer 11 Jan 2022, 19:55
ATXS CATABASIS PHARMACEUTICALS INC 02 Jun 2021 1 $0 4 Director 02 Jun 2021, 19:14